 however, it may be limited by
the discrepancy in arterial seal zone diameters as well
as by the ability to pass the stent through tortuous
anatomy.216
The liquid embolic agent n-butyl 2-cyanoacrylate
(NBCA) has been used to treat cases of both ruptured
and unruptured GDAA and PDAA.222 A theoretical
advantage of embolization with liquid embolic agents
is